BIOMAT Database Logo BIOMAT Database Logo

Do maternally acquired antibodies protect infants from malaria infection? 2001

E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. eleanor.riley@lshtm.ac.uk

Neonates and infants are relatively protected from clinical malaria, but the mechanism of this protection is not well understood. Maternally derived antibodies are commonly believed to provide protection against many infectious diseases, including malaria, for periods of up to 6-9 months but several recent epidemiological studies have produced conflicting results regarding a protective role of passively acquired antimalarial antibodies. In this article, we review the epidemiological evidence for resistance of young infants to malaria, summarize the data on antimalarial antibody levels and specificity and their association with protection from malaria infection or clinical disease, and explore alternative explanations for resistance to malaria in infants.

UI MeSH Term Description Entries
D007112 Immunity, Maternally-Acquired Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Fetal Immunity, Maternally-Acquired,Maternally-Acquired Immunity,Neonatal Immunity, Maternally-Acquired,Immunity, Maternally Acquired,Fetal Immunities, Maternally-Acquired,Fetal Immunity, Maternally Acquired,Immunity, Maternally-Acquired Fetal,Immunity, Maternally-Acquired Neonatal,Maternally Acquired Immunities,Maternally Acquired Immunity,Maternally-Acquired Fetal Immunities,Maternally-Acquired Fetal Immunity,Maternally-Acquired Immunities,Maternally-Acquired Neonatal Immunities,Maternally-Acquired Neonatal Immunity,Neonatal Immunities, Maternally-Acquired,Neonatal Immunity, Maternally Acquired
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.
May 2000, Journal of virology,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria.
May 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Fetal and neonatal death from maternally acquired infection.
January 2001, Paediatric and perinatal epidemiology,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Postnatal decline of maternally acquired rubella antibodies.
September 1970, The Journal of hygiene,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.
May 2014, Science (New York, N.Y.),
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Does milk protect infants against malaria?
January 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Loss of maternally acquired measles antibodies in well-nourished infants and response to measles vaccination, Peru.
June 1990, American journal of public health,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Do untreated bednets protect against malaria?
January 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Postnatal decline of maternally acquired antibodies in the rat.
January 1976, Biology of the neonate,
E M Riley, and G E Wagner, and B D Akanmori, and K A Koram
Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
August 1987, Science (New York, N.Y.),
Copied contents to your clipboard!